Navigation Links
Aggressively Treating Cardiac Risk Factors May Reverse Ischemia
Date:10/25/2007

ALEXANDRIA, Va., Oct. 26 /PRNewswire-USNewswire/ -- People with diabetes who have asymptomatic heart disease may be able to vastly improve the flow of blood to their hearts without surgical intervention, according to a study being published in the November issue of Diabetes Care, which comes out on October 26, 2007.

Researchers found that patients with obstructed blood flow (known as ischemia) who aggressively treated their cardiac risk factors with medication were able to reverse the course of heart disease over a three-year period.

Patients were given stress tests to measure how well blood was flowing to the heart at the beginning of the study and again at the end. Though none of the patients exhibited symptoms of heart disease, 20 percent fared poorly on their stress tests, showing signs of obstructed blood flow. However, three years later, 79 percent of those whose initial stress tests were abnormal no longer showed any sign of obstruction.

The reversal came as a surprise to researchers, who had anticipated a worsening of ischemia, since type 2 diabetes is "an important aggravating risk factor" for the progression of cardiovascular disease. People with diabetes are two to four times more likely to develop heart disease than those who don't have diabetes. While the study was not designed to measure the impact of heart medications on ischemia, researchers did note that those whose stress tests returned to normal had increased their use of aspirin, statins and ACE inhibitors, all prescribed to help control cardiovascular risk factors.

Typically, doctors treat obstructed blood flow to the heart with surgical interventions, such as angioplasty or bypass surgery. This study suggests that alternative treatments, such as medication, may also be effective. Further research is needed to confirm these findings.

For more information about this study, please contact lead researcher Dr. Frans J. Th. Wackers, Yale University School of Medicine, at email: frans.wackers@yale.edu or by phone: 203-785-4915.

Diabetes Care, published by the American Diabetes Association, is the leading peer-reviewed journal of clinical research into the nation's fifth leading cause of death by disease. Diabetes also is a leading cause of heart disease and stroke, as well as the leading cause of adult blindness, kidney failure, and non-traumatic amputations. For more information about diabetes, visit the American Diabetes Association Web site http://www.diabetes.org or call 1-800-DIABETES (1-800-342-2383).


'/>"/>
SOURCE American Diabetes Association
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Gene Therapy shows promise in treating Hemophilia
2. Treating eye pain eases migraine
3. Treating wounds without stitches
4. Treating varicose veins
5. Treating acne with laser
6. Ketoconazole 2% more effective in treating Seborrheic Dermatitis
7. Once-Daily Cipro(R) XR for Treating Complicated Urinary Tract Infections
8. Treating Stroke Patients in Rural Areas
9. Free Tissue Transfer Effective in Treating Massive Skin Cancers
10. Treating Blocked Arteries In The Lower Limbs
11. Zinc Supplements Found To Be Effective In Treating Children With ADHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... 22, 2017 , ... Silicon Valley startup Enke Life has ... Their electric toothbrushes aggressively attack oral bacteria by reducing dental plaque and other ... edge Enke technology with a premium timeless design, they want to redefine the ...
(Date:9/22/2017)... ... September 22, 2017 , ... Egg ... life. Although frozen embryos have a slight statistical advantage for live births, frozen ... a wonderful opportunity for women undergoing medical treatment or who are concerned about ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability Indices for ... 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality in device ... of The Quality System Regulation (§820.250), and Devicemakers find themselves staring at a ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... of a new member survey conducted by the International Society of Hair ... from 2014 to 2016 rose 60 percent, with 635,189 procedures performed in 2016. ...
(Date:9/21/2017)... ... 21, 2017 , ... Innovatum will demonstrate capabilities of fully ... Conference 2017 in Chicago, IL on October 17-19, 2017. This unique development addresses ... patient safety. , Microscan , a global technology leader in barcoding, ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly and ... will present new data for galcanezumab and lasmiditan, two ... the International Headache Society (IHC) taking place Sept. 7-10 ... Lilly will highlight new, long-term data from an open-label ... of galcanezumab (120 mg and 240 mg) for the ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
(Date:8/29/2017)... , Aug. 29, 2017 ivWatch, LLC, the leading provider ... infiltrations, announced it has been awarded an Innovative Technology contract from ... the country. ... device to aid in the early detection of peripheral IV infiltration ... The Innovative Technology contract ...
Breaking Medicine Technology: